Clinical Effects of Metformin on Fertility-sparing Treatment for Early

Updated 04/23/2024

Status Recruiting

Clinical Trial Summary

The purpose of the study is to investigate the effects of metformin in addition to the conventional progestin therapy in the fertility-sparing treatment of early stage endometrial cancer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04792749
Study type	Interventional
Source	Samsung Medical Center
Contact	Joseph Noh, M.D.
Phone	+82-10-9756-3249
Email	joseph.noh@samsung.com
Status	Recruiting
Phase	Phase 3
Start date	June 1, 2021
Completion date	March 31, 2024

See also
	Status	Clinical Trial	Phase
	Not yet recruiting	`NCT04046185` - Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer	Early Phase 1
	Active, not recruiting	`NCT03469674` - PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer	Phase 3
	Not yet recruiting	`NCT06278857` - SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)	Phase 2
	Completed	`NCT04972682` - [SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer	N/A
	Recruiting	`NCT05179447` - PROfiling Based Endometrial Cancer Adjuvant Therapy	N/A
	Recruiting	`NCT04073706` - Sentinel Node Biopsy in Endometrial Cancer	Phase 3
	Recruiting	`NCT04291612` - Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
	Recruiting	`NCT04839614` - Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia	N/A
	Completed	`NCT03580421` - Cost-utility of Ambulatory Surgery in the Management of Endometrial Cancer(AMBU-ENDO)	N/A